Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
1190 participants
INTERVENTIONAL
2020-08-10
2022-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Early Screen for Discharge Planning in Community Hospitals
NCT02117804
The Impact of Individual-based Discharges From Acute Admission Units to Home
NCT02295319
Post-Acute Physician Home Visit Program
NCT03178513
READI (Readiness Evaluation And Discharge Interventions) Study
NCT01873118
Paramedic Coached ED Care Transitions to Help Older Adults Maintain Their Health
NCT02520661
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
It is standard practice for HIM teams to make and coordinate outpatient appointments and activities including radiologic procedures for discharging patients. During this study, usual care will continue for patients in each arm. The intervention (Video-visit) is in addition to and not in place of the usual standard of care.
If issues/concerns beyond the scope of the video visit or telephone follow-up arise, then the PEARL APP will direct these to the discharging hospitalist team/supervising physician, or the participant's primary care provider (PCP) consistent with current standards of practice and management of post-discharge issues. Issues re-directed to the discharging hospitalist team or other providers will be documented in the Video-visit encounter. If the APP deems the clinical situation urgent or emergent, the APP will refer the patient to emergency services, or if needed ask the patient his/her location and contact 911. The APP will also immediately notify the study PI or co-PI who are both hospitalists and familiar with the practice. The APP will also notify the discharging hospitalist team.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Video Visit and Standard of Care
Participants will participate in a video visit and standard of care
Standard of Care
Outpatient appointments and activities including radiologic procedures for discharging patients as standard of practice
Video Visit
15-20 minute Video visit with an advanced practice provider (nurse practitioner or physician assistant) approximately 2-5 days after discharge.
Standard of Care
Participants will participate in standard of care for discharged patients.
Standard of Care
Outpatient appointments and activities including radiologic procedures for discharging patients as standard of practice
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Standard of Care
Outpatient appointments and activities including radiologic procedures for discharging patients as standard of practice
Video Visit
15-20 minute Video visit with an advanced practice provider (nurse practitioner or physician assistant) approximately 2-5 days after discharge.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients discharged from a Hospital Internal Medicine service at Saint Marys Hospital
* Patients or their legally authorized representative provides consent to participate in the study
* Patients discharged home or to assisted living facility
Exclusion Criteria
* Patient discharged with Care Transitions Program, or to Hospice, skilled nursing facility (SNF) or long-term acute care (LTAC) facility
* Post-procedure patients (i.e., elective hospital admission for planned intervention or procedure)
* Patient/legally authorized representative is Non-English speaking
* Patient leaves the hospital Against Medical Advice (AMA)
* No access to mobile technology/laptop/computer for post-discharge follow-up
* Patient with an active diagnosis Covid-19 infection
* Patients with a scheduled re-admission for a procedure, chemotherapy, or other treatment
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mayo Clinic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sagar Dugani
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Chandrasagar (Sagar) Dugani, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Mayo Clinic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mayo Clinic in Rochester
Rochester, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Dugani SB, Kiliaki SA, Nielsen ML, Fischer KM, Lunde M, Kesselring GM, Lawson DK, Coons TJ, Schenzel HA, Parikh RS, Pagali SR, Liwonjo A, Croghan IT, Schroeder DR, Burton MC. Postdischarge Video Visits for Adherence to Hospital Discharge Recommendations: A Randomized Clinical Trial. Mayo Clin Proc Digit Health. 2023 Sep;1(3):368-378. doi: 10.1016/j.mcpdig.2023.06.006. Epub 2023 Aug 4.
Related Links
Access external resources that provide additional context or updates about the study.
Mayo Clinic Clinical Trials
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20-004688
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.